Cargando…

Potential role and mechanism of IFN-gamma inducible protein-10 on receptor activator of nuclear factor kappa-B ligand (RANKL) expression in rheumatoid arthritis

INTRODUCTION: IFN-gamma inducible protein-10 (CXCL10), a member of the CXC chemokine family, and its receptor CXCR3 contribute to the recruitment of T cells from the blood stream into the inflamed joints and have a crucial role in perpetuating inflammation in rheumatoid arthritis (RA) synovial joint...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Eun Young, Seo, MiRan, Juhnn, Yong-Sung, Kim, Jeong Yeon, Hong, Yoo Jin, Lee, Yun Jong, Lee, Eun Bong, Song, Yeong Wook
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218919/ https://www.ncbi.nlm.nih.gov/pubmed/21708014 http://dx.doi.org/10.1186/ar3385

Ejemplares similares

Atorvastatin inhibits osteoclastogenesis by decreasing the expression of RANKL in the synoviocytes of rheumatoid arthritis
por: Kim, Jeong Yeon, et al.
Publicado: (2012)

Expression of osteoprotegerin and its ligands, RANKL and TRAIL, in rheumatoid arthritis
por: Remuzgo-Martínez, Sara, et al.
Publicado: (2016)

Tofacitinib Prevents Radiographic Progression in Rheumatoid Arthritis
por: Kim, Joon Wan, et al.
Publicado: (2013)

Receptor activator of nuclear factor kappa-B ligand (RANKL) but not sclerostin or gene polymorphisms is related to joint destruction in early rheumatoid arthritis
por: Boman, Antonia, et al.
Publicado: (2017)

Periodontitis is associated with rheumatoid arthritis: a study with longstanding rheumatoid arthritis patients in Korea
por: Choi, In Ah, et al.
Publicado: (2016)

CCAAT/enhancer-binding protein β promotes receptor activator of nuclear factor-kappa-B ligand (RANKL) expression and osteoclast formation in the synovium in rheumatoid arthritis
por: Tsushima, Hidetoshi, et al.
Publicado: (2015)

Clinical characteristics associated with occurrence and poor prognosis of interstitial lung disease in rheumatoid arthritis
por: Yang, Ji Ae, et al.
Publicado: (2019)

Tocilizumab Increases Body Weight and Serum Adipokine Levels in Patients with Rheumatoid Arthritis Independently of Their Treatment Response: a Retrospective Cohort Study
por: Choi, In Ah, et al.
Publicado: (2020)

The importance of cell surface RANKL in rheumatoid arthritis
por: Krystufkova, O, et al.
Publicado: (2005)

Downregulation of heat shock protein 70 protects rheumatoid arthritis fibroblast-like synoviocytes from nitric oxide-induced apoptosis
por: Kang, Eun Ha, et al.
Publicado: (2009)

Therapeutic effect of a novel histone deacetylase 6 inhibitor, CKD-L, on collagen-induced arthritis in vivo and regulatory T cells in rheumatoid arthritis in vitro
por: Oh, Bo Ram, et al.
Publicado: (2017)

α-Tocopheryl Succinate Inhibits Osteoclast Formation by Suppressing Receptor Activator of Nuclear Factor-kappaB Ligand (RANKL) Expression and Bone Resorption
por: Kim, Ha-Neui, et al.
Publicado: (2012)

Synergistic induction of CX3CL1 by TNF alpha and IFN gamma in osteoblasts from rheumatoid arthritis: involvement of NF-kappa B and STAT-1 signaling pathways
por: Isozaki, Takeo, et al.
Publicado: (2008)

Association between anti-Porphyromonas gingivalis or anti-α-enolase antibody and severity of periodontitis or rheumatoid arthritis (RA) disease activity in RA
por: Lee, Joo Youn, et al.
Publicado: (2015)

Is RANKL inhibition both anti-resorptive and anabolic in rheumatoid arthritis?
por: Sims, Natalie A., et al.
Publicado: (2015)

RANKL is a therapeutic target of bone destruction in rheumatoid arthritis
por: Tanaka, Sakae
Publicado: (2019)

Evaluation of the anti-RANKL monoclonal antibody in rheumatoid arthritis rats
por: Lv, Dawei, et al.
Publicado: (2022)

IFN-β for the treatment of rheumatoid arthritis?
por: Tak, P, et al.
Publicado: (2003)

Understanding IFNλ in rheumatoid arthritis
por: de Groen, Rik A, et al.
Publicado: (2014)

Effect of Cornus Officinalis on Receptor Activator of Nuclear Factor-kappaB Ligand (RANKL)-induced Osteoclast Differentiation
por: Kim, Jung Young, et al.
Publicado: (2012)

Eleutherococcus sessiliflorus Inhibits Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL)-Induced Osteoclast Differentiation and Prevents Ovariectomy (OVX)-Induced Bone Loss
por: Han, Sang-Yong, et al.
Publicado: (2021)

Inhibition of non-homologous end joining of gamma ray-induced DNA double-strand breaks by cAMP signaling in lung cancer cells
por: Noh, Sung-Eun, et al.
Publicado: (2020)

Mortality, disability, and healthcare expenditure of patients with seropositive rheumatoid arthritis in Korea: A nationwide population-based study
por: Choi, In Ah, et al.
Publicado: (2019)

Exogenous IFN-beta regulates the RANKL-c-Fos-IFN-beta signaling pathway in the collagen antibody-induced arthritis model
por: Zhao, Rong, et al.
Publicado: (2014)

Impact of temporary methotrexate discontinuation for 2 weeks on immunogenicity of seasonal influenza vaccination in patients with rheumatoid arthritis: a randomised clinical trial
por: Park, Jin Kyun, et al.
Publicado: (2018)

Cell-type-specific Modulation of Non-homologous End Joining of Gamma Ray-induced DNA Double-strand Breaks by cAMP Signaling in Human Cancer Cells
por: Noh, Sung-Eun, et al.
Publicado: (2020)

Majoon Chobchini attenuates arthritis disease severity and RANKL-mediated osteoclastogenesis in rheumatoid arthritis
por: Samarpita, Snigdha, et al.
Publicado: (2021)

Evaluation of the Receptor Activator of Nuclear Factor Kappa B Ligand (RANKL) Expression in Osteosarcoma and Its Association with the Clinicopathological Data
por: Chua, Hui Heng, et al.
Publicado: (2021)

Interleukin-7 Induces Osteoclast Formation via STAT5, Independent of Receptor Activator of NF-kappaB Ligand
por: Kim, Jin-Hee, et al.
Publicado: (2017)

N-acetyl-l-cysteine controls osteoclastogenesis through regulating Th17 differentiation and RANKL in rheumatoid arthritis
por: Kim, Hae-Rim, et al.
Publicado: (2019)

Nuclear factor kappaB (NF-kappaB) pathway as a therapeutic target in rheumatoid arthritis.
por: Jue, D. M., et al.
Publicado: (1999)

Corrigendum: Interleukin-7 Induces Osteoclast Formation via STAT5, Independent of Receptor Activator of NF-kappaB Ligand
por: Kim, Jin-Hee, et al.
Publicado: (2017)

Receptor activator of NF-kappaB ligand (RANKL) and CD 31 expressions in chronic periodontitis patients before and after surgery
por: Friedmann, Anton, et al.
Publicado: (2014)

Erratum to “Low Baseline Interleukin-17A Levels Are Associated with Better Treatment Response at 12 Weeks to Tocilizumab Therapy in Rheumatoid Arthritis Patients”
por: Lee, Sang Jin, et al.
Publicado: (2017)

Low Baseline Interleukin-17A Levels Are Associated with Better Treatment Response at 12 Weeks to Tocilizumab Therapy in Rheumatoid Arthritis Patients
por: Lee, Sang Jin, et al.
Publicado: (2015)

OPG and RANKL in serum and synovial fluids of patients with rheumatoid arthritis, osteoarthritis and spondylarthropathy
por: Krystufkova, O, et al.
Publicado: (2003)

N-acetyl-l-cysteine controls osteoclastogenesis through regulating Th17 differentiation and RANKL production in rheumatoid arthritis
por: Kim, Hae-Rim, et al.
Publicado: (2019)

Efficacy and safety of tocilizumab in Korean patients with active rheumatoid arthritis
por: Baek, Han Joo, et al.
Publicado: (2019)

Attenuated RANKL-induced cytotoxicity by Portulaca oleracea ethanol extract enhances RANKL-mediated osteoclastogenesis
por: Erkhembaatar, Munkhsoyol, et al.
Publicado: (2015)

High Proportion of Subjective Component to the Disease Activity Score is Associated with Favorable Response to Abatacept in Rheumatoid Arthritis
por: Lee, Jeong Seok, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_erucsqaptspc5ettbfl459ittj